...
首页> 外文期刊>Pharmacology and Therapeutics: The Journal of the International Encyclopedia of Pharmacology and Therapeutics >SNPing cancer in the bud: MicroRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer
【24h】

SNPing cancer in the bud: MicroRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer

机译:SNPing处于萌芽状态的癌症:MicroRNA和microRNA靶位点多态性作为癌症的诊断和预后生物标志物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs are master regulators of gene expression and control many biological pathways such as cell growth, differentiation and apoptosis. Deregulation of microRNA expression and activity results in a myriad of diseases including cancer. Recently, several reports have indicated that single nucleotide polymorphisms (SNPs) in microRNAs and microRNA-target sites impact microRNA biology and associate with cancer risk, treatment response and outcome. In this review we will describe these findings and discuss the possible future of utilizing these SNPs as diagnostic and prognostic markers in the clinic. ? 2012 Elsevier Inc.
机译:MicroRNA是基因表达的主要调节因子,可控制许多生物学途径,例如细胞生长,分化和凋亡。 microRNA表达和活性的失控导致多种疾病,包括癌症。最近,一些报告表明,microRNA和microRNA靶位点中的单核苷酸多态性(SNP)影响microRNA生物学,并与癌症风险,治疗反应和结果相关。在这篇综述中,我们将描述这些发现,并讨论在临床中将这些SNPs用作诊断和预后标志物的可能性。 ? 2012爱思唯尔公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号